[HTML][HTML] Plasma angiotensin II is increased in critical coronavirus disease 2019

RL Camargo, B Bombassaro… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-
converting enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested …

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

D Batlle, J Wysocki, K Satchell - Clinical science, 2020 - portlandpress.com
A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of
severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019 …

[HTML][HTML] ACE2, much more than just a receptor for SARS-COV-2

L Samavati, BD Uhal - Frontiers in cellular and infection microbiology, 2020 - frontiersin.org
The rapidly evolving pandemic of severe acute respiratory syndrome coronavirus (SARS-
CoV-2) infection worldwide cost many lives. The angiotensin converting enzyme-2 (ACE-2) …

A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

M Oz, DE Lorke, N Kabbani - Pharmacology & therapeutics, 2021 - Elsevier
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications

AM Davidson, J Wysocki, D Batlle - Hypertension, 2020 - Am Heart Assoc
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 originated from Wuhan,
China, in December 2019 and rapidly spread to other areas worldwide. Since then …

Angiotensin‐converting enzyme 2: the old door for new severe acute respiratory syndrome coronavirus 2 infection

HW Tan, YM Xu, ATY Lau - Reviews in medical virology, 2020 - Wiley Online Library
Summary Coronavirus (CoV) disease 2019 (COVID‐19) is an ongoing pandemic caused by
severe acute respiratory syndrome CoV 2 (SARS‐CoV‐2). The highly contagious SARS …

[HTML][HTML] Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19

J Fu, B Zhou, L Zhang, KS Balaji, C Wei, X Liu… - Molecular biology …, 2020 - Springer
The ACE2 gene is a receptor of SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) for COVID-19 (coronavirus disease 2019). To analyze the expression profiles …

[HTML][HTML] Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage

N Kirtipal, S Kumar, SK Dubey, VD Dwivedi… - Infection, Genetics and …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accountable for causing
the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease …

[HTML][HTML] Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19

K Kuba, T Yamaguchi, JM Penninger - Frontiers in immunology, 2021 - frontiersin.org
Seventeen years after the epidemic of SARS coronavirus, a novel coronavirus SARS-CoV-2-
emerged resulting in an unprecedented pandemic. Angiotensin-converting enzyme 2 …

[HTML][HTML] Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management

M Liu, T Wang, Y Zhou, Y Zhao, Y Zhang… - Journal of translational …, 2020 - degruyter.com
COVID-19 is the current public health threat all over the world. Unfortunately, there is no
specific prevention and treatment strategy for this disease. We aim to explore the potential …